1Engineer L, Ahmed AR. Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data. J Am Acad Dermatol, 2001 , 44:83 - 88.
2Mouthon L, Kaveri SV, Spalter SH, et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol, 1996, 104:3-9.
3Spuls PI, Brakman M, Westerhof W, et al. Treatment of generalized bullous pemphigoid with topical corticosteroids. Acta Derm Venereol,1995, 75:89.
4Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topicat corticosteroids in patients with bullous pemphigoid. N Engl J Med,2002, 346:321 - 327.
5Fivenson DP, Breneman DL, Rosen GB, et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol, 1994, 130:753 - 758.
6Loo WJ, Kirtschig G, Wojnarowska F. Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol, 2001, 26:376.
7Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA, 2000, 284:350 -356.
8Lebrun-Vignes B, Roujeau JC, Bernard P, et al. Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid. Arch Dermatol, 1999, 135:89-90.
9Egan CA, Meadows KP, Zone JJ. Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int J Dematol, 2000, 39:230 -235.
10Bohm M, Beissert S, Schwarz T, et al. Bullous pemphigoid treated with mycophenolate mofetil. Lancet, 1997, 349:541.
